Far too many hurdles continue to prevent people living with obesity from accessing obesity treatments that could lead to significant weight loss, said Mike Mason, executive vice president and president, Lilly Diabetes and Obesity
66 Targeting multiple peptide hormone receptors with the same drug entity appears to be the most promising strategy, where additive, or even synergistic, benefits of simultaneously activating two receptor signalling pathways in bone can be fully realised
Development of an antioxidant system after early weaning in piglets
In vitro and animal studies suggest DIM has anti-inflammatory 17 and chemoprotective effects
CVS steps up to help GLP-1 customers New approach includes lower-cost access, pharmacist support and products to help manage common side effects June 23, 2026 As demand for GLP-1 medications continues to increase across the U.S., CVS Health on Monday announced a comprehensive approach to GLP-1 support spanning its more than 9,000 CVS Pharmacy locations and MinuteClinic, available virtually in nearly all states
Conditional knockout mouse models targeting the GLP-1R in smooth muscle cells will be needed to address this issue